在巨核细胞分化过程中,GFI1B和LSD1抑制了髓状细胞的特征
Jeron Venhuizen1, Maaike G J M van Bergen1, Saskia M Bergevoet1
1Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands.
Communications biology
|March 29, 2024
概括
增长因子独立性1B (GFI1B) 变异影响巨核细胞中的基因程序. GFI1B-LSD1的相互作用对巨核形成和抑制髓状细胞分化至关重要.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 增长因子独立1B (GFI1B) 是一个转录因子,对巨核细胞和血小板发育至关重要.
- 致病性GFI1B变种会导致不同程度的血小板缺血和出血障碍.
- 不同GFI1B变异影响的特定基因程序尚未完全理解.
研究的目的:
- 调查四种患者衍生的GFI1B变异对巨核细胞的转录效应.
- 阐明GFI1B-lysine特定甲基酶1A (LSD1) 相互作用在巨核形成和骨髓体分化中的作用.
主要方法:
- 对具有患者衍生GFI1B变异的MEG01巨核细胞的转录组分析.
- 诱导多能干细胞 (iPSC) 衍生的单细胞RNA测序巨核细胞.
- 使用GSK-LSD1.1.使用GFI1B-LSD1相互作用的药理抑制.
主要成果:
- 四种GFI1B变种中的每一种 (GFI1BT174N,H181Y,R184P,Q287*) 都影响了不同的基因程序.
- 独特的是,GFI1BQ287*变体未能抑制骨髓分化基因.
- 抑制GFI1B-LSD1相互作用模仿了GFI1BQ287*变体的影响,激活了髓状基因.
结论:
- GFI1B和LSD1协作促进巨核形成,同时抑制骨髓分化.
- GFI1B-LSD1复合体在维持巨核细胞和髓状细胞系之间的平衡方面发挥着至关重要的作用.
- 了解GFI1B变异效应,可以深入了解血小板缺血病原.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


